Quantcast

Latest Prostate Stories

2014-02-27 16:27:35

WASHINGTON, Feb. 27, 2014 /PRNewswire-USNewswire/ -- ZERO - The End of Prostate Cancer is hosting more than 30 run/walk events across the nation to raise funds and awareness to end prostate cancer, a disease that affects one in seven American men. http://photos.prnewswire.com/prnvar/20130129/DC50244LOGO "Thousands are making a choice for a healthy lifestyle by walking or running to help end prostate cancer," ZERO CEO Jamie Bearse said. "With the help of our 100-plus local partner...

2014-02-27 08:29:54

Novel Prognostic Test Is Designed to Guide Optimal Decision-Making at Diagnosis CAMBRIDGE, Mass., Feb. 27, 2014 /PRNewswire/ -- Metamark Genetics, Inc. today announced that its Cambridge, Mass. laboratory has been licensed for the highest level of clinical testing in the use of ProMark(TM), the company's prognostic assay to guide the medical management of patients with prostate cancer. The licensure by the State of Massachusetts for "high-complexity testing" establishes the...

2014-02-26 12:25:59

New prostate cancer screening option combines existing tests to substantially increase accuracy CHICAGO, Feb. 26, 2014 /PRNewswire-USNewswire/ -- Northwestern Medicine(®) is the first health care provider in the country to offer a new non-invasive blood test for prostate cancer that is nearly three times more accurate than the current standard prostate-specific antigen (PSA) blood test. Known as the Prostate Health Index (phi), the new test's accuracy will effectively remove the...

2014-02-23 23:02:43

The use of a new technology called High Intensity Focused Ultrasound (HIFU) waves to treat prostate cancer without surgery on an out-patient basis moves closer to U.S. approval thanks to Dr. Michael J. Lazar, Jr. and other urologists utilizing this next-generation technology with patients in other nations. SANTA ROSA, California (PRWEB) February 23, 2014 HIFU technology achieves pinpoint accuracy using an “acoustic scalpel” that destroys prostate cancer, while sparing healthy tissue...

2014-02-20 23:32:07

Profound Medical announces initiation of U.S. clinical trial for its novel, minimally invasive technology for the treatment of localized prostate cancer. Toronto, Ontario (PRWEB) February 20, 2014 Today, Profound Medical Inc. announced the initiation of the TULSA (Trans Urethral Ultrasound Ablation) clinical trial in the United States. The first US patient was treated on January 25, 2014 and the procedure was performed at Beaumont Hospital, Royal Oak by urologist, James Relle, M.D. “We...

2014-02-19 23:00:12

Research Study Testing Effectiveness of New Outpatient Treatment for Localized Prostate Cancer Royal Oak, MI (PRWEB) February 20, 2014 Urologists at Beaumont Hospital, Royal Oak are first in the U.S. to treat localized prostate cancer with a transurethral ultrasound therapy guided by magnetic resonance imaging. The experimental treatment is designed to potentially reduce the long-term complications of traditional prostate cancer treatments. The first treatment on Jan. 25 marked the launch...

2014-02-14 16:25:05

DALLAS, Feb. 14, 2014 /PRNewswire/ -- In his February 3, 2014 Op-Ed piece in The New York Times, Dr. John La Pluma says "men feel the loss" if their testosterone is lower than 220 to 350 ng/dl. La Pluma's misstatement of laboratory values is consistent with his glaring lack of knowledge relative to testosterone deficiency. (Photo: http://photos.prnewswire.com/prnh/20140214/DA65642) As the Medical Director for the largest hormone replacement company in the country with more...

2014-02-12 23:26:02

Prostate problems need not affect a man’s quality of life. Avail of Prosvent under the special 30-day trial period to get rid of prostate issues and enjoy better health. Los Angeles, Ca (PRWEB) February 12, 2014 With over 2 million bottles sold, Dr. Larry May’s Prosvent formula is indeed one of the most effective homeopathic treatment formulas for prostate-related problems. As men become older, prostate problems arise. Right now, almost 30 million males suffer from this condition. The...

2014-02-11 23:22:56

The marketing of therapy for low testosterone highlights the short-term benefits but serious concerns remain about possible long-term risks. Boston, MA (PRWEB) February 11, 2014 Millions of American men use a prescription testosterone gel, patch, or injection to boost levels of the manly hormone. The ongoing marketing blitz promises that treating "low T" this way can make men feel more alert, energetic, mentally sharp, and sexually functional. However, legitimate safety concerns...

2014-02-06 08:28:18

TORONTO, Feb. 6, 2014 /CNW/ - Men with metastatic castration-resistant prostate cancer (mCRPC) in Québec now have access to a therapy that can be used prior to chemotherapy. Effective February 3, 2014, the province has added ZYTIGA(®) (abiraterone acetate) to the public drug formulary for the treatment of mCRPC in men who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy (ADT).(1) "ZYTIGA(® )provides men and health care professionals with a...


Latest Prostate Reference Libraries

Prostate
2013-03-04 15:21:55

The male prostate gland acts as an exocrine gland in the male reproductive system. It is a firm, partly muscular, chestnut sized gland near the neck of the urethra in males. Formation and Orientation The prostate is usually formed within the ninth week of the embryonic stage in reproductive development. The prostate can be separated into either “lobes” or “zones”. When looking at a prostate divided into zones, there are four distinct regions. The first zone is the Peripheral...

More Articles (1 articles) »
Word of the Day
tessitura
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.